Metabolic syndrome and angiotensin II receptor antagonists

Aim. To investigate the effects of angiotensin II receptor antagonist irbesartan on blood pressure (BP), tissue insulin sensitivity, carbohydrate and lipid metabolism, cerebral perfusion parameters in patients with arterial hypertension (AH), metabolic syndrome (MS), and Type 2 diabetes mellitus (DM...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	K. M. Mamyrbayeva, V. B. Mychka, V. B. Sergienko, I. E. Chazova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2007-04-01
Subjects:	arterial hypertension metabolic syndrome diabetes mellitus irbesartan
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1191